KRISTENE SMITH: Open Payments
NPI 1003521238 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 32 payments from 10 companies in 2025. Trend: 2023 $1,033 · 2024 $814 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $338 |
| Otsuka America Pharmaceutical, Inc. | 7 | $190 |
| Vanda Pharmaceuticals Inc. | 4 | $113 |
| ABBVIE INC. | 5 | $111 |
| Lundbeck LLC | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| OWP Pharmaceuticals, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: CAPLYTA, REXULTI, FANAPT, VRAYLAR, Qelbree, ABILIFY ASIMTUFII, Auvelity, TRINTELLIX.
Industry payments across MD — which companies pay providers there.
